Log in
ASX:FFC

FarmaForce Limited (FFC.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
FarmaForce Limited provides services as a contract sales organization to pharmaceutical industry in Australia. The company operates in two segments, Contract Sales and Marketing Services to External Customers; and Services to Related Parties. It also offers sales, data, and medical affairs solutions. The company was founded in 2014 and is based in Sydney, Australia. FarmaForce Limited is a subsidiary of The iQ Group Global Ltd.

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Care Facilities
Sub-IndustryN/A
SectorMedical
Current SymbolASX:FFC
Previous Symbol
CUSIPN/A
CIKN/A
Webfarmaforce.com.au
Phone61 2 8239 5400
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio0.41
Quick Ratio0.41

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$13.98 million
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA($0.02) per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive FFC News and Ratings via Email

Sign-up to receive the latest news and ratings for FFC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











FarmaForce Limited (FFC.AX) (ASX:FFC) Frequently Asked Questions

What stocks does MarketBeat like better than FarmaForce Limited (FFC.AX)?

Wall Street analysts have given FarmaForce Limited (FFC.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but FarmaForce Limited (FFC.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of FarmaForce Limited (FFC.AX)'s key competitors?

Some companies that are related to FarmaForce Limited (FFC.AX) include Asian American Medical Group Limited (AJJ.AX) (AJJ), Encompass Health (EHC), Field Trip Health (FTRPF), Fresenius SE & Co. KGaA (FRE.F) (FRE), Greenbrook TMS (GBOKF), Healthia Limited (HLA.AX) (HLA), JD Health International (JDHIF), Life Healthcare Group (LTGHY), Medicover AB (publ) (MCVEF), Orpea (ORPEF), Ramsay Health Care (RMYHY), Sienna Senior Living (LWSCF) and Sourcebio International Plc (SBI.L) (SBI).
View all of FFC's competitors.

Who are FarmaForce Limited (FFC.AX)'s key executives?

FarmaForce Limited (FFC.AX)'s management team includes the following people:
  • Dr. George Syrmalis M.D., Ph.D., Group CEO & Exec. Director (Age 54, Pay $50k)
  • Ms. Clair O'Gorman, Head of Operations
  • Ms. Athena Kolivos M.A., M.P.H., Chief Scientific Officer of Farmaforce & CRC
  • Mr. Ghay Haidar B.Sc., Sales Director
  • Ms. Natalie Urner, Head of Commercial Partnerships
  • Mr. Gerardo Incollingo, Company Sec.

What is FarmaForce Limited (FFC.AX)'s stock symbol?

FarmaForce Limited (FFC.AX) trades on the ASX under the ticker symbol "FFC."

How big of a company is FarmaForce Limited (FFC.AX)?

FarmaForce Limited (FFC.AX) has a market capitalization of $0.00 and generates $13.98 million in revenue each year.

What is FarmaForce Limited (FFC.AX)'s official website?

The official website for FarmaForce Limited (FFC.AX) is farmaforce.com.au.

How can I contact FarmaForce Limited (FFC.AX)?

The company can be reached via phone at 61 2 8239 5400.

This page was last updated on 1/19/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.